Glucose-6-phosphate dehydrogenase deficiency and psychotic disorders: A systematic review

References

• Alving AS, Carson PE, Flanagan CL, Ickes CE. 1956. Enzymatic deficiency in primaquine-Sensitive erythrocytes. Science. 124(3220):484–485. doi:10.1126/science.124.3220.484.b.
   PubMed Web of Science ®Google Scholar
• Baehner RL, Nathan DG, Castle WB. 1971. Oxidant injury of Caucasian glucose-6-phosphate dehydrogenase—deficient red blood cells by phagocytosing leukocytes during infection. J Clin Invest. 50(12):2466–2473. doi:10.1172/JCI106747.
   PubMed Web of Science ®Google Scholar
• Baron M, Straub RE, Lehner T, Endicott J, Ott J, Gilliam TC, Lerer B. 1994. Bipolar disorder and linkage to Xq28. Nat Genet. 7(4):461–462. doi:10.1038/ng0894-461a.
   PubMedGoogle Scholar
• Bernaudin F, Verlhac S, Chevret S, Torres M, Coic L, Arnaud C, Kamdem A, Hau I, Grazia Neonato M, Delacourt C, et al. 2008. G6PD deficiency, absence of α-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood. 112(10):4314–4317. doi:10.1182/blood-2008-03-143891.
   PubMed Web of Science ®Google Scholar
• Beutler E. 1994. G6PD deficiency.
   Google Scholar
• Beutler E. 1996. G6PD: population genetics and clinical manifestations. Blood Rev. 10(1):45–52. 1996/03/01/doi:10.1016/s0268-960x(96)90019-3.
   PubMed Web of Science ®Google Scholar
• Bhutani VK, Johnson-Hamerman L. 2015. The clinical syndrome of bilirubin-induced neurologic dysfunction. Semin Fetal Neonatal Med. 20(1):6–13. doi:10.1016/j.siny.2014.12.008.
   PubMed Web of Science ®Google Scholar
• Bitanihirwe BK, Woo TU. 2011. Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev. 35(3):878–893. doi:10.1016/j.neubiorev.2010.10.008.
   PubMed Web of Science ®Google Scholar
• Bocchetta A. 2003. Psychotic mania in glucose-6-phosphate-dehydrogenase-deficient subjects. Ann Gen Hosp Psychiatry. 2(1):6. doi:10.1186/1475-2832-2-6.
   PubMedGoogle Scholar
• Bocchetta A, Piccardi MP, Zompo MD. 1994. Is bipolar disorder linked to Xq28? Nat Genet. 6(3):224–224. doi:10.1038/ng0394-224.
   PubMed Web of Science ®Google Scholar
• Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, Stewart L. 2012. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev. 1(1):2. doi:10.1186/2046-4053-1-2.
   PubMedGoogle Scholar
• Bowman JE, Brewer GJ, Frischer H, et al. 1965. A re-evaluation of the relationship between glucose-6-phosphate dehydrogenase deficiency and the behavioral manifestations of schizophrenia. J Lab Clin Med. 65(2):222–227.
   PubMed Web of Science ®Google Scholar
• Cabungcal J-H, Steullet P, Kraftsik R, Cuenod M, Do KQ. 2013. Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine. Biol Psychiatry. 73(6):574–582. doi:10.1016/j.biopsych.2012.09.020.
   PubMed Web of Science ®Google Scholar
• Cao L, Zhang D, Chen J, Qin Y-Y, Sheng R, Feng X, Chen Z, Ding Y, Li M, Qin Z-H, et al. 2017. G6PD plays a neuroprotective role in brain ischemia through promoting pentose phosphate pathway. Free Radic Biol Med. 112:433–444. doi:10.1016/j.freeradbiomed.2017.08.011.
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Fiorelli G. 2008. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 371(9606):64–74. doi:10.1016/S0140-6736(08)60073-2.
   PubMed Web of Science ®Google Scholar
• Carcassi UE. 1974. The interaction between beta-thalassemia, G-6-PD deficiency, and favism. Ann N Y Acad Sci. 232(0):297–305. doi:10.1111/j.1749-6632.1974.tb20594.x.
   PubMedGoogle Scholar
• Carson PE, Frischer H. 1966. Glucose-6-phosphate dehydrogenase deficiency and related disorders of the pentose phosphate pathway. Am J Med. 41(5):744–761. doi:10.1016/0002-9343(66)90035-0.
   PubMed Web of Science ®Google Scholar
• Chan TK, Todd D, Wong CC. 1965. Tissue enzyme levels in erythrocyte glucose-6-phosphate dehydrogenase deficiency. J Lab Clin Med. 66(6):937–942.
   PubMed Web of Science ®Google Scholar
• Connell J, Kim A, Brummel NE, Patel MB, Vandekar SN, Pandharipande P, Dittus RS, Heckers S, Ely EW, Wilson JE, et al. 2021. Advanced age is associated with catatonia in critical illness: results from the delirium and catatonia prospective cohort investigation. Front Psychiatry. 12:673166. doi:10.3389/fpsyt.2021.673166.
   PubMed Web of Science ®Google Scholar
• Del Zompo M, Bocchetta A, Goldin LR, Corsini GU. 1984. Linkage between X-chromosome markers and manic-depressive illness. Acta Psychiatr Scand. 70(3):282–287. doi:10.1111/j.1600-0447.1984.tb01210.x.
   PubMed Web of Science ®Google Scholar
• Dern R, Glynn M, Brewer G. 1962. Studies on the influence of hereditary G6PD deficiency in the expression of schizophrenic patterns. Clin Res. 10:80.
   Google Scholar
• Dern RJ, Glynn MF, Brewer GJ. 1963. Studies on the correlation of the genetically determined trait, glucose-6-phosphate dehydrogenase deficiency, with behavioral manifestations in schizophrenia. J Lab Clin Med. 62(2):319–329.
   PubMed Web of Science ®Google Scholar
• El Waly B, Macchi M, Cayre M, Durbec P. 2014. Oligodendrogenesis in the normal and pathological Central nervous system. Front Neurosci. 8:145. doi:10.3389/fnins.2014.00145.
   PubMed Web of Science ®Google Scholar
• Elyassi AR, Rowshan HH. 2009. Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature. Anesth Prog. 56(3):86–91. doi:10.2344/0003-3006-56.3.86.
   PubMedGoogle Scholar
• Feo F, Pirisi L, Pascale R, Daino L, Frassetto S, Zanetti S, Garcea R. 1984. Modulatory mechanisms of chemical carcinogenesis: the role of the NADPH Pool in the benzo(a)pyrene activation. Toxicol Pathol. 12(3):261–268. doi:10.1177/019262338401200309.
   PubMedGoogle Scholar
• Fieve RR, Brauninger G, Fleiss J, Cohen G. 1965. Glucose-6-phosphate dehydrogenase deficiency and schizophrenic behavior. J Psychiatr Res. 3(4):255–262. doi:10.1016/0022-3956(65)90006-3.
   PubMed Web of Science ®Google Scholar
• Gawryluk JW, Wang J-F, Andreazza AC, Shao L, Young LT. 2011. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol. 14(1):123–130. doi:10.1017/S1461145710000805.
   PubMed Web of Science ®Google Scholar
• Goi T, Shionoya Y, Sunada K, Nakamura K. 2019. General anesthesia in a glucose-6-phosphate dehydrogenase deficiency child: a case report. Anesth Prog. 66(2):94–96. doi:10.2344/anpr-66-01-05.
   PubMedGoogle Scholar
• Gómez-Manzo S, Marcial-Quino J, Vanoye-Carlo A, Serrano-Posada H, Ortega-Cuellar D, González-Valdez A, Castillo-Rodríguez RA, Hernández-Ochoa B, Sierra-Palacios E, Rodríguez-Bustamante E, et al. 2016. Glucose-6-phosphate dehydrogenase: update and analysis of new mutations around the world. Int J Mol Sci. 17(12):2069. doi:10.3390/ijms17122069.
   PubMed Web of Science ®Google Scholar
• Ivanova SA, Smirnova LP, Shchigoreva YG, Boiko AS, Semke AV, Uzbekov MG, Bokhan NA. 2014. Glucose-6-phosphate dehydrogenase and catalase activities in erythrocytes of schizophrenic patients under pharmacotherapy with traditional antipsychotics. Neurochem J. 8(1):66–70. doi:10.1134/S1819712414010061.
   Google Scholar
• Katsel P, Roussos P, Pletnikov M, Haroutunian V. 2017. Microvascular anomaly conditions in psychiatric disease. Schizophrenia - angiogenesis connection. Neurosci Biobehav Rev. 77:327–339. doi:10.1016/j.neubiorev.2017.04.003.
   PubMed Web of Science ®Google Scholar
• Khairova R, Pawar R, Salvadore G, Juruena MF, de Sousa RT, Soeiro-de-Souza MG, Salvador M, Zarate CA, Gattaz WF, Machado-Vieira R, et al. 2012. Effects of lithium on oxidative stress parameters in healthy subjects. Mol Med Rep. 5(3):680–682.
   PubMed Web of Science ®Google Scholar
• Leopold JA, Cap A, Scribner AW, Stanton RC, Loscalzo J. 2001. Glucose‐6‐phosphate dehydrogenase deficiency promotes endothelial oxidant stress and decreases endothelial nitric oxide bioavailability. Faseb J. 15(10):1771–1773. doi:10.1096/fj.00-0893fje.
   PubMed Web of Science ®Google Scholar
• Lepping P, Delieu J, Mellor R, Williams JHH, Hudson PR, Hunter-Lavin C. 2011. Antipsychotic medication and oxidative cell stress: a systematic review. J Clin Psychiatry. 72(3):273–285. doi:10.4088/JCP.09r05268yel.
   PubMed Web of Science ®Google Scholar
• Leza JC, García-Bueno B, Bioque M, Arango C, Parellada M, Do K, O'Donnell P, Bernardo M. 2015. Inflammation in schizophrenia: a question of balance. Neurosci Biobehav Rev. 55:612–626. doi:10.1016/j.neubiorev.2015.05.014.
   PubMed Web of Science ®Google Scholar
• Loniewska MM, Gupta A, Bhatia S, MacKay-Clackett I, Jia Z, Wells PG. 2020. DNA damage and synaptic and behavioural disorders in glucose-6-phosphate dehydrogenase-deficient mice. Redox Biol. 28:101332. doi:10.1016/j.redox.2019.101332.
   PubMed Web of Science ®Google Scholar
• Luzzatto L, Ally M, Notaro R. 2020. Glucose-6-phosphate dehydrogenase deficiency. Blood. 136(11):1225–1240. doi:10.1182/blood.2019000944.
   PubMed Web of Science ®Google Scholar
• Luzzatto L, Nannelli C, Notaro R. 2016. Glucose-6-phosphate dehydrogenase deficiency. Hematol Oncol Clin North Am. 30(2):373–393. doi:10.1016/j.hoc.2015.11.006.
   PubMed Web of Science ®Google Scholar
• Maiocchi L, Bernardi E. 2012. Acute anterior compartment syndrome associated with psychogenic polydipsia. Australas Psychiatry. 20(2):159–161. doi:10.1177/1039856211432465.
   PubMed Web of Science ®Google Scholar
• Matsuzawa D, Obata T, Shirayama Y, Nonaka H, Kanazawa Y, Yoshitome E, Takanashi J, Matsuda T, Shimizu E, Ikehira H, et al. 2008. Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study. PLoS One. 3(4):e1944. doi:10.1371/journal.pone.0001944.
   PubMed Web of Science ®Google Scholar
• Mendlewicz J, Linkowski P, Wilmotte J. 1980. Linkage between glucose-6-phosphate dehydrogenase deficiency and manic-depressive psychosis. Br J Psychiatry. 137(4):337–342. doi:10.1192/bjp.137.4.337.
   PubMedGoogle Scholar
• Monsivais SR, Wisdom N, Kruse JL, Davis MC. 2016. N-Acetylcysteine supplementation in an individual with glucose-6-phosphate dehydrogenase deficiency-associated psychosis. Biol Psychiatry. 80(8):e71-2–e72. doi:10.1016/j.biopsych.2016.02.028.
   PubMed Web of Science ®Google Scholar
• Munn Z, Moola S, Riitano D, Lisy K. 2014. The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag. 3(3):123–128. doi:10.15171/ijhpm.2014.71.
   PubMedGoogle Scholar
• Nasr SJ. 1976. Glucose-6-phosphate dehydrogenase deficiency with psychosis. Arch Gen Psychiatry. 33(10):1202–1203. doi:10.1001/archpsyc.1976.01770100064006.
   PubMed Web of Science ®Google Scholar
• Nasr S, Altman E, Pscheidt G, et al. 1982. Glucose-6-phosphate dehydrogenase deficiency in a psychiatric population: a preliminary study. Biol Psychiatry. 17(8):925–928.
   PubMed Web of Science ®Google Scholar
• Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. 2009. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 42(3):267–278. doi:10.1016/j.bcmd.2008.12.005.
   PubMed Web of Science ®Google Scholar
• Ogunro PS, Eegunranti BA, Atiba AS, Oke EO, Akande JO. 2013. Status of antioxidant defense and lipid peroxidation in schizophrenics with positive, negative and cognitive symptoms. Free Radicals Antioxid. 3(1):20–24. doi:10.1016/j.fra.2013.03.005.
   Google Scholar
• Osime E, Onuigbo F, Samuel S. 2018. Evaluation of glucose-6-phosphate dehydrogenase activity and hematological changes in psychotic patients undergoing antipsychotic chemotherapy in Benin city [original article. Sahel Med J. 21(1):37–41. doi:10.4103/smj.smj_51_16.
   Google Scholar
• Ou Z, Chen Y, Li J, Ouyang F, Liu G, Tan S, Huang W, Gong X, Zhang Y, Liang Z, et al. 2020. Glucose-6-phosphate dehydrogenase deficiency and stroke outcomes. Neurology. 95(11):e1471–e1478. doi:10.1212/WNL.0000000000010245.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. 2021. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372:n71. doi:10.1136/bmj.n71.
   PubMed Web of Science ®Google Scholar
• Pong S, Karmacharya R, Sofman M, Bishop JR, Lizano P. 2020. The role of brain microvascular endothelial cell and Blood-Brain barrier dysfunction in schizophrenia. Complex Psychiatry. 6(1–2):30–46. doi:10.1159/000511552.
   PubMedGoogle Scholar
• Puthumana JS, Regenold WT. 2019. Glucose-6-phosphate dehydrogenase activity in bipolar disorder and schizophrenia: relationship to mitochondrial impairment. J Psychiatr Res. 112:99–103. doi:10.1016/j.jpsychires.2019.03.004.
   PubMed Web of Science ®Google Scholar
• Raj V, Chism K, Minckler MR, Denysenko L. 2014. Catatonia and glucose-6-phosphate dehydrogenase deficiency: a report of two cases and a review. Psychosomatics. 55(1):92–97. Jan- doi:10.1016/j.psym.2013.06.011.
   PubMed Web of Science ®Google Scholar
• Robins E, Guze SB. 1970. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 126(7):983–987. doi:10.1176/ajp.126.7.983.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Rodriguez P, Almeida A, Bolaños JP. 2013. Brain energy metabolism in glutamate-receptor activation and excitotoxicity: role for APC/C-Cdh1 in the balance glycolysis/pentose phosphate pathway. Neurochem Int. 62(5):750–756. doi:10.1016/j.neuint.2013.02.005.
   PubMed Web of Science ®Google Scholar
• Saeed TK, Hamamy H, Alwan A. 1985. Association of glucose‐6‐phosphate dehydrogenase deficiency with diabetes mellitus. Diabet Med. 2(2):110–112. doi:10.1111/j.1464-5491.1985.tb00611.x.
   PubMedGoogle Scholar
• Shapiro SM. 2005. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol. 25(1):54–59. doi:10.1038/sj.jp.7211157.
   PubMedGoogle Scholar
• Singh V, Kishore N, Kumar D, Sengupta S. 2012. Glucose-6 phosphate dehydrogenase deficiency and psychotic illness. Indian J Psychol Med. 34(3):270–272. doi:10.4103/0253-7176.106027.
   PubMedGoogle Scholar
• Spiegel DR, Holtz L, Chopra K. 2010. A case of mania in a patient with systemic lupus erythematosus: can its inflammatory pathogenesis be applied to primary mood disorders? Psychiatry (Edgmont). 7(4):31–36.
   PubMedGoogle Scholar
• Suboc TM, Dharmashankar K, Wang J, et al. 2014. Roles of aldosterone, mineralocorticoid inhibition and G6PD activity in microvascular endothelial dysfunction in african americans with hypertension. Circulation. 130(suppl_2):A18279–A18279.
   Google Scholar
• Sydnor VJ, Roalf DR. 2020. A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: implications for studies of psychosis risk. Schizophr Res. 226:61–69. doi:10.1016/j.schres.2020.06.028.
   PubMed Web of Science ®Google Scholar
• Tachibana M, Ishizuka K, Inada T. 2022. Catatonia and delirium: similarity and overlap of acute brain dysfunction. Front Psychiatry. 13:876727. doi:10.3389/fpsyt.2022.876727.
   PubMed Web of Science ®Google Scholar
• Tajjudin A, Hooper AI. 2019. J. Case report of a rare asenapine induced tachycardia in a bipolar affective disorder patient with underlying glucose-6Phosphate deficiency. Malays J Sci Health Technol. 3(1):5–7.
   Google Scholar
• Tang BL. 2019. Neuroprotection by glucose-6-phosphate dehydrogenase and the pentose phosphate pathway. J Cell Biochem. 120(9):14285–14295. doi:10.1002/jcb.29004.
   PubMed Web of Science ®Google Scholar
• Tzortzatou-Stathopoulou F, Zannos-Mariolea L, Karayiannis P, Constantsas N, Matsaniotis N. 1980. Leucocyte glucose-6-phosphate dehydrogenase (g-6-pd) activity in g-6-pd deficient subjects. Eur J Pediatr. 135(1):37–39. doi:10.1007/BF00445890.
   PubMed Web of Science ®Google Scholar
• Ventriglio, Antonio, Bellomo, Antonello, Donato, Favale, Iris, Bonfitto, Giovanna, Vitrani, Dario, Di Sabatino, Edwige, Cuozzo, Pettorruso, Mauro, Perna, Giampaolo, Valchera, Alessandro, et al. Oxidative stress in the early stage of psychosis. Curr Top Med Chem. 2021;21(16):1457–1470. doi:10.2174/1568026621666210701105839.
   PubMed Web of Science ®Google Scholar
• Wan G-H, Tsai S-C, Chiu DT-Y. 2002. Decreased blood activity of glucose-6-phosphate dehydrogenase associates with increased risk for diabetes mellitus. Endocrine. 19(2):191–195. doi:10.1385/ENDO:19:2:191.
   PubMed Web of Science ®Google Scholar
• Webster R, Holroyd S. 2000. Prevalence of psychotic symptoms in delirium. Psychosomatics. 41(6):519–522. doi:10.1176/appi.psy.41.6.519.
   PubMed Web of Science ®Google Scholar
• Wusthoff CJ, Loe IM. 2015. Impact of bilirubin-induced neurologic dysfunction on neurodevelopmental outcomes. Semin Fetal Neonatal Med. 20(1):52–57. doi:10.1016/j.siny.2014.12.003.
   PubMed Web of Science ®Google Scholar
• Yao JK, Leonard S, Reddy R. 2006. Altered glutathione redox state in schizophrenia. Dis Markers. 22(1–2):83–93. doi:10.1155/2006/248387.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhao Z, He L, Wan C. 2010. A meta-analysis of oxidative stress markers in schizophrenia. Sci China Life Sci. 53(1):112–124. doi:10.1007/s11427-010-0013-8.
   PubMed Web of Science ®Google Scholar